Release Date: 12/12/11 14:52 Summary: Final Director's Interest Notice - RA Illingworth Price Sensitive: No Download Document 350.37KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%